This interview reviews the current challenges to patients and their care teams and highlights how advancing technologies can facilitate the delivery of care.
One such technology is Aptar Pharma’s HeroTracker® Sense. This innovation has the potential to reduce the burden of chronic respiratory diseases on HCPs, nurse practitioners and patients. This novel connected healthcare device transforms a standard metered dose inhaler into a connected healthcare device. It provides valuable feedback to patients to help them use their pMDI as intended and supports their inhalation technique. It also provides valuable analytics to the HCP and insights into patient training and onboarding, thereby helping care teams to better understand real-life situations and use of pMDIs, and adapt treatment plans accordingly.
Learn more about Aptar Pharma’s expertise in Digital Health
This Might Also Be of Interest
Using digital therapeutics to improve inhaler use and patient outcomes
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions
COVID-19 intensifies need for and uptake of digital healthcare
Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation
The Need to Scale Up Digital Health in the Post-Covid World
Webinars, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions, Innovation & Insights, Drug Delivery Innovations
Applying Connectivity to Enhance The Training Standard of Care for Self-Injection
Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation
